Skip to main content
SpringerLink
Log in

OESOPHAGEAL CANCER

Adjuvant nivolumab for resected gastroesophageal cancer

  • In Brief
  • Published:

From Nature Reviews Gastroenterology & Hepatology

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

Original article

  • Kelly, R. J. et al. Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer. N. Engl. J. Med. 384, 1191–1203 (2021)

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Nature Reviews Gastroenterology & Hepatology http://www.nature.com/nrgastro/

    Jordan Hindson

Authors
  1. Jordan Hindson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jordan Hindson.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hindson, J. Adjuvant nivolumab for resected gastroesophageal cancer. Nat Rev Gastroenterol Hepatol 18, 368 (2021). https://doi.org/10.1038/s41575-021-00466-w

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41575-021-00466-w

  • Springer Nature Limited

Search

Navigation